QUANTUM GENOMICSQUANTUM GENOMICSQUANTUM GENOMICS

QUANTUM GENOMICS

No trades
See on Supercharts
Market capitalization
‪3.83 M‬EUR
−0.0920EUR
‪−3.17 M‬EUR
‪10.06 K‬EUR
‪28.57 M‬
Beta (1Y)
0.83

About QUANTUM GENOMICS

CEO
Jean-Philippe Milon
Headquarters
Paris
Founded
2005
ISIN
FR0011648971
FIGI
BBG005P8LG22
Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. It focuses on the development of drug class based on the central action mechanism of Aminopeptidase A inhibition. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALQGC is 0.1150 EUR — it has increased by 4.36% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange QUANTUM GENOMICS stocks are traded under the ticker ALQGC.
QUANTUM GENOMICS is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
ALQGC stock is 5.09% volatile and has beta coefficient of 0.83. Check out the list of the most volatile stocks — is QUANTUM GENOMICS there?
Yes, you can track QUANTUM GENOMICS financials in yearly and quarterly reports right on TradingView.
ALQGC stock has risen by 12.52% compared to the previous week, the month change is a 11.00% rise, over the last year QUANTUM GENOMICS has showed a 15.44% decrease.
ALQGC net income for the last quarter is ‪−1.19 M‬ EUR, while the quarter before that showed ‪−1.99 M‬ EUR of net income which accounts for 40.30% change. Track more QUANTUM GENOMICS financial stats to get the full picture.
Today QUANTUM GENOMICS has the market capitalization of ‪3.80 M‬, it has decreased by 2.14% over the last week.
No, ALQGC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALQGC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade QUANTUM GENOMICS stock right from TradingView charts — choose your broker and connect to your account.
ALQGC reached its all-time high on Jun 19, 2015 with the price of 14.2042 EUR, and its all-time low was 0.0804 EUR and was reached on Oct 25, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So QUANTUM GENOMICS technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating QUANTUM GENOMICS stock shows the sell signal. See more of QUANTUM GENOMICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. QUANTUM GENOMICS EBITDA is ‪−3.14 M‬ EUR, and current EBITDA margin is ‪−31.26 K‬%. See more stats in QUANTUM GENOMICS financial statements.